2008Zhongguo yaofangRequires access

Pharmacokinetics and Bioequivalence of Nimesulide Orally Disintegrating Tablets in Healthy Volunteers

Lixin Yin

Open publisher page 0 citations

Abstract

OBJECTIVE:To evaluate the bioavailability of two nimesulide preparations.METHODS:A total of 20 healthy male volunteers were enrolled in a randomized crossover study in which the subjects were randomly assigned to receive single dose of 200 mg nimesulide orally disintegrating tablets(test)or nimesulide tablets(reference).The plasma concentrations of nimesulide were determined by RP-HPLC,and the pharmacokinetic parameters and bioavailability were calculated with DAS program.RESULTS:The main pharmacokinetic parameters of nimesulide test and reference preparations were as follow:AUC0~24:(54.67±18.25)vs.(56.15±15.54)μg·h·mL-1;AUC0~∞:(56.38±18.03)vs.(57.63±15.26)μg·h·mL-1;Cmax:(7.61±2.72)vs.(7.50±2.19)μg·mL-1;tmax:(3.83±1.39)and(3.80±1.28)h.The relative bioavailability of nimesulide or-ally disintegrating tablets as against nimesulide tablet was(98.7±22.9)%.CONCLUSION:Nimesulide test and reference preparations were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To evaluate the bioavailability of two nimesulide preparations.METHODS:A total of 20 healthy male volunteers were enrolled in a randomized crossover study in which the subjects were randomly assigned to receive single dose of 200 mg nimesulide orally disintegrating tablets(test)or nimesulide tablets(reference).The plasma concentrations of nimesulide were determined by RP-HPLC,and the pharmacokinetic parameters and bioavailability were calculated with DAS program.RESULTS:The main pharmacokinetic parameters of nimesulide test and reference preparations were as follow:AUC0~24:(54.67±18.25)vs.(56.15±15.54)μg·h·mL-1;AUC0~∞:(56.38±18.03)vs.(57.63±15.26)μg·h·mL-1;Cmax:(7.61±2.72)vs.(7.50±2.19)μg·mL-1;tmax:(3.83±1.39)and(3.80±1.28)h.The relative bioavailability of nimesulide or-ally disintegrating tablets as against nimesulide tablet was(98.7±22.9)%.CONCLUSION:Nimesulide test and reference preparations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To evaluate the bioavailability of two nimesulide preparations.METHODS:A total of 20 healthy male volunteers were enrolled in a randomized crossover study in which the subjects were randomly assigned to receive single dose of 200 mg nimesulide orally disintegrating tablets(test)or nimesulide tablets(reference).The plasma concentrations of nimesulide were determined by RP-HPLC,and the pharmacokinetic parameters and bioavailability were calculated with DAS program.RESULTS:The main pharmacokinetic parameters of nimesulide test and reference preparations were as follow:AUC0~24:(54.67±18.25)vs.(56.15±15.54)μg·h·mL-1;AUC0~∞:(56.38±18.03)vs.(57.63±15.26)μg·h·mL-1;Cmax:(7.61±2.72)vs.(7.50±2.19)μg·mL-1;tmax:(3.83±1.39)and(3.80±1.28)h.The relative bioavailability of nimesulide or-ally disintegrating tablets as against nimesulide tablet was(98.7±22.9)%.CONCLUSION:Nimesulide test and reference preparations were bioequivalent.

Key concepts: Nimesulide, Bioequivalence, Bioavailability, Pharmacokinetics, Cmax, Pharmacology, Crossover study, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and Bioequivalence of Nimesulide Orally Disintegrating Tablets in Healthy Volunteers — Research Paper | ScholarLens